Go to ValuEngine.com

October 6 , 2016


VALUATION WATCH: Overvalued stocks now make up 48.29% of our stocks assigned a valuation and 15.63% of those equities are calculated to be overvalued by 20% or more. Seven sectors are calculated to be overvalued.

If you cannot display this bulletin properly, GO HERE

Ch-Ch-Ch-Changes

--ValuEngine: Significant Turnover in NASDAQ 100 Top- Stock List

ValuEngine tracks more than 7000 US equities, ADRs, and foreign stock which trade on US exchanges as well as @1000 Canadian equities.  When EPS estimates are available for a given equity, our model calculates a level of mispricing or valuation percentage for that equity based on earnings estimates and what the stock should be worth if the market were totally rational and efficient--an academic exercise to be sure, but one which allows for useful comparisons between equities, sectors, and industries. Using our Valuation Model, we can currently assign a VE valuation calculation to more than 2800 stocks in our US Universe.

We also use trading data to provide forecast estimates for a variety of time horizons for almost ever equity in our database. Our Buy/Sell/Hold recommendations are based upon the 1-year forecast return figure. Using valuation and forecast figures, you can rank and rate our covered stocks against each other, to find out, in an objective and systematic way, the most attractive investment targets based on your own risk/reward parameters. We re-calculate the entire database every trading day, so you are assured that every proprietary valuation and forecast datapoint is as up-to-date as possible.

We can use our data to track individual stocks, industries, sectors, and indices. For today's bulletin, we present key metrics for the top picks in the NASDAQ 100. The companies listed below represent the top-ten BUY and STRONG BUY stocks within the index. They are presented below according to their one-month forecast target prices.

For the first time in quite a while, we see very significant turnover in our NASDAQ top-ten list. Since our last report in September, we have 80% turnover/eight new companies in our list. But not all is new this month. Applied Materials (AMAT) remains locked in place as our number one NASDAQ stock. We also have LAM Research (LRCX) falling five positions-- from third-to-eighth spot.

The newcomers consist of CBS Corp, Navient, United Rentals, Mallinckrodt, Tyson Foods, KLA-Tencor, Scripps Networks, and Johnson Controls. The big turnover has replaced Net-Ease, Intel, Broadcom, Cisco Systems, Facebook, Amgen, Ebay, and Computer Associates.

Ticker
Company Name
Market Price
Valuation
Last 12-M Retrn
1-M Forecast Retn
1-Yr Forecast Retn
P/E Ratio
Sector
9-1-2016 Leaders
AMAT
APPLD MATLS INC
29.94
-6.33%
98.28%
1.13%
13.63%
18.37
Computer and Technology
AMAT
CBS
CBS CORP
56.41
-12.40%
35.47%
1.13%
13.57%
14.65
Consumer Discretionary
NTES
NAVI
NAVIENT CORP
14.78
3.84%
28.75%
1.13%
13.55%
7.99
Finance
LRCX
URI
UTD RENTALS INC
80.58
1.33%
25.10%
1.07%
12.85%
9.95
Construction
INTC
MNK
MALLINCKRODT PL
71.07
-18.12%
15.73%
1.07%
12.85%
8.50
Medical
AVGO
TSN
TYSON FOODS  A
73.77
2.18%
64.26%
1.05%
12.57%
16.32
Consumer Staples
CSCO
KLAC
KLA-TENCOR CORP
71.21
0.71%
37.66%
1.04%
12.49%
14.19
Computer and Technology
FB
LRCX
LAM RESEARCH
96.17
2.88%
47.00%
1.03%
12.36%
15.17
Computer and Technology
AMGN
SNI
SCRIPPS NETWRKS
63.78
-3.19%
24.33%
1.01%
12.12%
12.10
Consumer Discretionary
EBAY
JCI
JOHNSON CONTRLS
45.95
-22.69%
25.85%
0.93%
11.19%
17.27
Industrial Products
CA

NOTE: New stocks are in BOLD, old stocks that have moved up the list are in GREEN, old stocks that have declined in position are in RED, and stocks which have retained their position are in CAPS. There are no STRONG BUY companies in this list, all stocks are rated BUY

Below is today's data on Mallinckrodt Plc (MNK):

Mallinckrodt Plc. is engaged in pharmaceuticals business. It develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company's Specialty Pharmaceuticals segment includes branded and generic drugs and Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt Plc. is based in Dublin, Ireland.

VALUENGINE RECOMMENDATION: ValuEngine continues its BUY recommendation on MALLINCKRODT PL for 2016-10-05. Based on the information we have gathered and our resulting research, we feel that MALLINCKRODT PL has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE P/E Ratio and Company Size.


You can download a free copy of detailed report on Mallinckrodt Plc (MNK) from the link below.


ValuEngine Forecast
 
Target
Price*
Expected
Return
1-Month
71.83 1.07%
3-Month
72.29 1.71%
6-Month
72.10 1.44%
1-Year
80.20 12.85%
2-Year
68.15 -4.11%
3-Year
50.59 -28.82%

Valuation & Rankings
Valuation
18.12% undervalued
Valuation Rank(?)
78
1-M Forecast Return
1.07%
1-M Forecast Return Rank
98
12-M Return
15.73%
Momentum Rank(?)
70
Sharpe Ratio
0.31
Sharpe Ratio Rank(?)
68
5-Y Avg Annual Return
13.21%
5-Y Avg Annual Rtn Rank
78
Volatility
42.36%
Volatility Rank(?)
42
Expected EPS Growth
-0.72%
EPS Growth Rank(?)
20
Market Cap (billions)
8.26
Size Rank
88
Trailing P/E Ratio
8.50
Trailing P/E Rank(?)
94
Forward P/E Ratio
8.56
Forward P/E Ratio Rank
89
PEG Ratio
n/a
PEG Ratio Rank
n/a
Price/Sales
2.42
Price/Sales Rank(?)
40
Market/Book
1.59
Market/Book Rank(?)
61
Beta
1.75
Beta Rank
15
Alpha
-0.12
Alpha Rank
31

DOWNLOAD A FREE SAMPLE OF OUR MALLINCKRODT (MNK) REPORT BY CLICKING HERE


 

 

ValuEngine Market Overview

Summary of VE Stock Universe
Stocks Undervalued
51.71%
Stocks Overvalued
48.29%
Stocks Undervalued by 20%
20.24%
Stocks Overvalued by 20%
15.63%

ValuEngine Sector Overview

Sector
Change
MTD
YTD
Valuation
Last 12-MReturn
P/E Ratio
0.60%
-0.38%
18.37%
7.41% overvalued
13.82%
24.26
0.43%
0.27%
19.01%
6.11% overvalued
11.00%
29.52
0.18%
-0.88%
10.36%
2.96% overvalued
11.07%
21.34
1.81%
1.79%
21.81%
2.75% overvalued
-2.46%
25.72
0.60%
0.08%
7.87%
2.61% overvalued
2.58%
20.86
0.88%
0.03%
1.94%
2.06% overvalued
7.65%
18.35
0.07%
-0.63%
10.39%
1.67% overvalued
12.02%
23.94
0.28%
-0.39%
7.08%
0.75% undervalued
4.70%
16.67
0.84%
-2.03%
41.71%
0.77% undervalued
52.41%
28.84
-0.10%
-0.05%
14.47%
1.52% undervalued
1.26%
24.72
0.31%
0.37%
10.04%
2.52% undervalued
3.82%
23.27
0.86%
0.76%
12.04%
2.76% undervalued
-11.62%
16.24
1.11%
1.24%
8.74%
2.96% undervalued
8.46%
14.04
0.76%
0.75%
3.12%
3.24% undervalued
-6.19%
26.67
0.61%
0.08%
31.87%
4.88% undervalued
14.34%
20.05
0.86%
0.70%
1.17%
5.31% undervalued
-2.46%
22.10

 

ValuEngine.com is an independent research provider, producing buy/hold/sell recommendations, target price, and valuations on over 7,000 US and Canadian equities every trading day. 
Visit www.ValuEngine.com for more information

 

 
 
Close this window
ValuEngine.com - Rational advice, smarter investing.